Rapid Drug Susceptibility Testing with a Molecular Beacon Assay Is Associated with Earlier Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in California

To assess the clinical impact of a molecular beacon (MB) assay that detects multidrug-resistant tuberculosis (MDR TB), we retrospectively reviewed records of 127 MDR TB patients with and without MB testing between 2004 and 2007. Use of the MB assay reduced the time to detection and treatment of MDR...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Banerjee, Ritu, Allen, Jennifer, Lin, S.-Y. Grace, Westenhouse, Janice, Desmond, Ed, Schecter, Gisela F., Scott, Cheryl, Raftery, Ann, Mase, Sundari, Watt, James P., Flood, Jennifer
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2010
Aiheet:
Mycobacteriology and Aerobic Actinomycetes
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2953075/
https://ncbi.nlm.nih.gov/pubmed/20702667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01236-10
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia